Guey Stéphanie, Kraemer Markus, Hervé Dominique, Ludwig Thomas, Kossorotoff Manoëlle, Bergametti Françoise, Schwitalla Jan Claudius, Choi Simone, Broseus Lucile, Callebaut Isabelle, Genin Emmanuelle, Tournier-Lasserve Elisabeth
Inserm UMR-S1161, Génétique et Physiopathologie des Maladies Cérébro-vasculaires, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
Department of Neurology, Alfried-Krupp-Hospital, Essen, Germany.
Eur J Hum Genet. 2017 Aug;25(8):995-1003. doi: 10.1038/ejhg.2017.92. Epub 2017 Jun 21.
Moyamoya angiopathy (MMA) is a cerebral angiopathy affecting the terminal part of internal carotid arteries. Its prevalence is 10 times higher in Japan and Korea than in Europe. In East Asian countries, moyamoya is strongly associated to the R4810K variant in the RNF213 gene that encodes for a protein containing a RING-finger and two AAA+ domains. This variant has never been detected in Caucasian MMA patients, but several rare RNF213 variants have been reported in Caucasian cases. Using a collapsing test based on exome data from 68 European MMA probands and 573 ethnically matched controls, we showed a significant association between rare missense RNF213 variants and MMA in European patients (odds ratio (OR)=2.24, 95% confidence interval (CI)=(1.19-4.11), P=0.01). Variants specific to cases had higher pathogenicity predictive scores (median of 24.2 in cases versus 9.4 in controls, P=0.029) and preferentially clustered in a C-terminal hotspot encompassing the RING-finger domain of RNF213 (P<10). This association was even stronger when restricting the analysis to childhood-onset and familial cases (OR=4.54, 95% CI=(1.80-11.34), P=1.1 × 10). All clinically affected relatives who were genotyped were carriers. However, the need for additional factors to develop MMA is strongly suggested by the fact that only 25% of mutation carrier relatives were clinically affected.
烟雾病性血管病(MMA)是一种影响颈内动脉终末段的脑血管病。其在日本和韩国的患病率比欧洲高10倍。在东亚国家,烟雾病与RNF213基因中的R4810K变异密切相关,该基因编码一种含有一个环指结构域和两个AAA+结构域的蛋白质。这种变异在白种人MMA患者中从未被检测到,但在白种人病例中已报道了几种罕见的RNF213变异。利用基于68例欧洲MMA先证者和573例种族匹配对照的外显子组数据的合并检验,我们发现欧洲患者中罕见的错义RNF213变异与MMA之间存在显著关联(优势比(OR)=2.24,95%置信区间(CI)=(1.19 - 4.11),P = 0.01)。病例特异性变异具有更高的致病性预测分数(病例中位数为24.2,对照为9.4,P = 0.029),并且优先聚集在一个包含RNF213环指结构域的C端热点区域(P < 10)。当将分析限制在儿童期发病和家族性病例时,这种关联更强(OR = 4.54,95% CI =(1.80 - 11.34),P = 1.1×10)。所有进行基因分型的临床受累亲属都是携带者。然而,只有25%的突变携带者亲属有临床症状这一事实强烈提示,MMA的发生需要其他因素。